Axel Polymers Q1 Results: Net loss widens to ₹10 lakh as revenue surges

2 min read     Updated on 16 Aug 2026, 10:39 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Axel Polymers reported a Q1FY27 standalone net loss of ₹10.07 lakh, reversing a profit of ₹13.73 lakh in Q1FY26. Revenue surged 700% YoY to ₹37.70 lakh, but costs outpaced income growth. The board approved the results on August 14, 2026. A compliance note highlights pending TDS reconciliations under the Income-tax Act, 2025, though management expects no material impact.

powered bylight_fuzz_icon
48402574

*this image is generated using AI for illustrative purposes only.

Axel Polymers Limited reported a significant deterioration in profitability for the first quarter of FY27, posting a standalone net loss of ₹10.07 lakh compared to a net profit of ₹13.73 lakh in Q1FY26. Despite a sharp surge in top-line growth, with revenue from operations jumping 700% year-on-year to ₹37.70 lakh, the company failed to convert this volume increase into earnings.

The Board of Directors, in its meeting held on August 14, 2026, approved the unaudited financial results based on the recommendations of the Audit Committee. The results have been filed with the stock exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Overview

The company’s total income from operations stood at ₹37.70 lakh for the quarter ended June 30, 2026, a substantial increase from ₹4.71 lakh in the corresponding period of FY25. This growth reflects higher business activity during the period. However, the cost structure expanded disproportionately, leading to a pre-tax loss of ₹9.82 lakh, compared to a pre-tax profit of ₹13.73 lakh in Q1FY25.

Metric: Q1FY27 (Unaudited): Q1FY26 (Unaudited): Change:
Revenue from Operations: ₹37.70 lakh ₹4.71 lakh +700.4%
Profit Before Tax: (₹9.82 lakh) ₹13.73 lakh Turned Loss
Net Profit After Tax: (₹10.07 lakh) ₹13.73 lakh Turned Loss
EPS (Basic): (₹0.04) ₹0.06 Negative

Earnings per share (basic) declined to (₹0.04) from ₹0.06 in the previous year’s corresponding quarter. The total comprehensive income for the period was also negative at ₹10.07 lakh.

What the Numbers Show

A critical divergence is visible between the company’s top-line expansion and its bottom-line contraction. While revenue grew seven-fold, the inability to maintain margin discipline resulted in a complete reversal of profitability. The shift from a ₹13.73 lakh profit to a ₹10.07 lakh loss indicates that operating expenses or cost of goods sold likely escalated at a rate far exceeding revenue growth. Without specific breakdowns of expense categories in the standalone extract, the data suggests a severe margin compression event in Q1FY27.

Regulatory Notes and Compliance

The financial statements were prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013. The company operates under a single segment as per Ind AS-108 ‘Segment Reporting’.

The filing includes a note on tax compliance. The company stated it has not complied with provisions relating to the deduction, deposit, and reporting of Tax Deducted at Source (TDS) as required under the Income-tax Act, 2025. The management noted that TDS balances and related statutory liabilities are subject to reconciliation and consequential adjustments have not been fully determined or accounted for in the financial results. However, the management does not expect any material adjustment affecting the financial statements upon such reconciliation.

Previous period figures have been regrouped and reclassified where necessary to make them comparable with current period figures. The equity share capital remained unchanged at ₹24.56 crore.

Historical Stock Returns for Axel Polymers

1 Day5 Days1 Month6 Months1 Year5 Years
+7.75%+12.95%+22.35%+15.15%-1.14%+217.07%

What specific operational inefficiencies or input cost escalations drove the disproportionate rise in expenses despite the 700% revenue surge?

How will the pending TDS reconciliation and potential statutory liabilities impact Axel Polymers' cash flow and future quarterly profitability?

Does the company have a concrete strategic roadmap to restore margin discipline and convert top-line growth into sustainable earnings in Q2FY27?

Axel Polymers delays Q4FY26 results due to auditor's medical exigency

1 min read     Updated on 19 Jun 2026, 02:29 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Axel Polymers Ltd delayed its Q4FY26 financial results submission due to the medical exigency of its Statutory Auditor. The Board meeting was rescheduled from May 30 to June 2, 2026, to approve the Standalone Audited Financial Results. The company has since submitted the results and committed to ensuring timely compliance going forward.

powered bylight_fuzz_icon
43405173

*this image is generated using AI for illustrative purposes only.

Axel Polymers Ltd has disclosed the reasons for the delay in submitting its audited financial results for the fourth quarter and year ended March 31, 2026. The delay was attributed to the medical exigency of the Statutory Auditor, which prevented the timely completion of the Statutory Auditor's Report. As a result, the financial results could not be placed before the Board of Directors for approval within the prescribed regulatory timeline.

The company had initially scheduled a meeting of its Board of Directors on May 30, 2026, to consider and approve the Standalone Audited Financial Results. However, due to the unavailability of the auditor's report, the meeting was rescheduled to June 2, 2026. The company informed the stock exchange about this change in schedule.

Following the rescheduled meeting, the Board considered and approved the Standalone Audited Financial Results for the period. The results have since been submitted to the stock exchange. The company expressed regret over the delay and assured stakeholders that adequate measures have been implemented to ensure timely compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in the future.

This disclosure was made in compliance with Regulation 33 of the SEBI (LODR) Regulations, 2015 and Para B of Section III-A of Chapter III of SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023.

Event Date
Initial Board Meeting May 30, 2026
Rescheduled Board Meeting June 2, 2026
Financial Year End March 31, 2026

Historical Stock Returns for Axel Polymers

1 Day5 Days1 Month6 Months1 Year5 Years
+7.75%+12.95%+22.35%+15.15%-1.14%+217.07%

What specific contingency plans has Axel Polymers established to prevent future delays due to auditor unavailability?

How might this delay impact investor confidence and the company's stock performance in the short term?

Will the company consider engaging a joint auditor or backup auditor to ensure continuity in financial reporting?

More News on Axel Polymers

1 Year Returns:-1.14%